Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
6
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
Duloxetine Lilly
Duloxetine Lilly is indicated in adults for: Treatment of major depressive disorder Treatment of diabetic peripheral neuropathic pain Treatment of generalised anxiety disorder Duloxetine Lilly is indicated in adults.
Duloxetine Boehringer Ingelheim
Treatment of diabetic peripheral neuropathic pain in adults.
View on EMACymbalta
Treatment of major depressive disorder. Treatment of diabetic peripheral neuropathic pain. Treatment of generalised anxiety disorder. Cymbalta is indicated in adults.
View on EMANodetrip (previously Xeristar)
Treatment of major depressive disorder; Treatment of diabetic peripheral neuropathic pain; Treatment of generalised anxiety disorder; Xeristar is indicated in adults.
View on EMAAriclaim
Treatment of diabetic peripheral neuropathic pain. Ariclaim is indicated in adults.
View on EMAYentreve
Yentreve is indicated for women for the treatment of moderate to severe stress urinary incontinence (SUI).
View on EMA